Recombinant Ebola Virus Disease Vaccine (Adenovirus Type 5 Vector)

More Serogroup: Men ACWY
Long lasting: immunization memory, High affinity IgG, Mucosal immunity.
Strong Evidence: A 10-year evidence of MenACWY CRM Menhycia® evidence.
Saftey: A 10-year evidence of Men ACWY CRM Menhycia® evidence Safety of CRM 197

...

• China's first bivalent meningococcal conjugate vaccine using CRM197 vector • Provides protection against two serotypes (group A and group C) • Safer and better

The third-generation technology

Produce humoral and cellular immunity

Stably stored and transported at 2–8°C

WHO Granted Emergency Use Listing (EUL) For Convidecia®

Approved in over 10 countries

The world's first inhaled COVID-19 vaccine Convidecia Air® has been approved as a booster dose in China, Morocco, and Indonesia. 

Induces humoral, cellular, and mucosal immunity

Needle-free vaccination